KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Non-Current Liabilities (2016 - 2025)

Quest Diagnostics' Total Non-Current Liabilities history spans 17 years, with the latest figure at $8.1 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 4.02% year-over-year to $8.1 billion; the TTM value through Dec 2025 reached $8.1 billion, down 4.02%, while the annual FY2025 figure was $8.1 billion, 4.02% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $8.1 billion at Quest Diagnostics, up from $7.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $8.4 billion in Q4 2024 and bottomed at $5.9 billion in Q1 2023.
  • The 5-year median for Total Non-Current Liabilities is $6.5 billion (2021), against an average of $6.9 billion.
  • The largest annual shift saw Total Non-Current Liabilities fell 8.33% in 2021 before it soared 36.09% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $6.3 billion in 2021, then decreased by 3.8% to $6.1 billion in 2022, then grew by 11.63% to $6.8 billion in 2023, then increased by 24.0% to $8.4 billion in 2024, then decreased by 4.02% to $8.1 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Total Non-Current Liabilities are $8.1 billion (Q4 2025), $7.9 billion (Q3 2025), and $7.8 billion (Q2 2025).